Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practiceNajeeb Shah, Thozhukat Sathyapalan, Mohammed Abdalla et al.|Therapeutic Advances in Endocrinology and Metabolism|2021Cited by 34
Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trialsMohammed Abdalla, Thozhukat Sathyapalan, Najeeb Shah et al.|Therapeutic Advances in Endocrinology and Metabolism|2022Cited by 31
Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta‐analysis of randomized controlled trialsMohammed Abdalla, Thozhukat Sathyapalan, Najeeb Shah et al.|Clinical Endocrinology|2021Cited by 21
Effect of pharmacological interventions on lipid profiles and C‐reactive protein in polycystic ovary syndrome: A systematic review and meta‐analysisMohammed Abdalla, Thozhukat Sathyapalan, Najeeb Shah et al.|Clinical Endocrinology|2021Cited by 21
Genetic risk for the polycystic ovary syndrome, bone mineral density and fractures in women and men: A UK Biobank Mendelian randomisation studyHarshal Deshmukh, Thozhukat Sathyapalan, Fadel Lhaf et al.|Bone|2021Cited by 5